Cyclo Therapeutics Inc (CYTH)

[JellyDonut]

The presentation included a physicians' report on the compassionate use of Trappsol® Cyclo™ administered intravenously for more than 7 years in 11 NPC patients. Trappsol® Cyclo™ was reported to be safe and well-tolerated in these patients. Individual patients in the compassionate use program exhibited responses systemically and/or in the central nervous system, including reduction in liver size and improvement in liver transaminases; resolution of interstitial lung disease; improvement in fine and gross motor skills; and improvement in quality of life.

This would explain, although still small, the uptick in volume. The last time they presented we went to .85. It's all good, everything going according to plan.